{"disease":{"id":"extrapulmonary-tuberculosis","name":"extrapulmonary tuberculosis"},"drugs":{"marketed":[{"drug_id":"cycloserine","indication_name":"Active Extrapulmonary Tuberculosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cyclorin","generic_name":"CYCLOSERINE","company_name":"Purdue Gmp","drug_phase":"marketed","molecular_target":"Glutamate receptor ionotropic, NMDA 2A","drug_class":"cycloserine","quality_score":49,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04122404","title":"POC Strategies to Improve TB Care in Advanced HIV Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":425,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT06875336","title":"A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"University of Cologne","has_results":false},{"nct_id":"NCT01252992","title":"Paradoxical Reactions in Non Immuno-compromized Patients With Extrapulmonary Tuberculosis","phase":"","overall_status":"COMPLETED","enrollment_count":135,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}